4AT Study
Start date:August 2015 End date:
Predicted June 2017 Co-ordinated by:
EMERGE team on behalf of University of Edinburgh and NHS Lothian Main trial site:
RIE
The 4AT as a triage test for delirium: a validation study in acutely hospitalised older patients.
Aim
To determine the diagnostic accuracy of the 4AT for delirium versus the reference standard of a DSM-IV diagnosis
Trial Design
Patients undergo a standard delirium assessment, and either the 4AT or the Confusion Assessment Method (CAM). Clinical outcomes and resource utilisation are recorded at 12 weeks after admission.
Eligibility criteria
Patients aged over 70 admitted to the Emergency Department.
Chief Investigator
Professor Alasdair MacLullich
Professor of Geriatric Medicine
Research Team
Allan MacRaild
Stroke Lead Research Nurse
Jill Steven
Senior Research Nurse - 4AT study
Mia Paderanga
Senior Research Nurse
Megan McGrath
Senior Research Nurse
Emma Ward
Research Administrator
Related news
4AT team attends British Geriatric Society conference
5 Nov 2015 | Allan MacRaild
Emerge sent two research nurses to the British Geriatric Society (BGS) conference. Jill Steven and Allan MacRaild are recruiting to a study entitled The 4AT as a triage test for delirium: a validation study in acutely hospitalised older patients. This study is a first collaboration between Emerge and Medicine of the Elderly with this study being led by Professor Alasdair MacLullich.
Read more
More EMERGE Trials
The purpose of this study is to test a new vaccine, ChAdOx1 nCoV-19, against COVID-19 in healthy volunteers.
The ChAdOx1 nCoV-19 vaccine has been developed in Oxford in an effort to protect healthy people from the pandemic. This study will evaluate the safety of the vaccine and its ability to generate an immune response against the virus.
This is a randomised trial. Participants will be randomly allocated to receive either the ChAdOx1 nCoV-19 vaccine, or a Men ACWY (meningitus vaccine). Volunteers will not be told which vaccine they will receive.
Participants will be asked to return for 6 visits across 12 months to evaluate their health.
Across the UK the trial aims to recruit 10,260 volunteers.
If you are interested in taking part, please click on this link and complete the online questionnaire: https://www.covid19vaccinetrial.co.uk/participate-edinburgh
COV_002 Vaccine Trial
The purpose of this study is to test a new vaccine against COVID-19 in healthy volunteers.